image dons

I make a donation

ADMIRAL

National multicentric trial aiming to evaluate the impact of Abciximab versus placebo in patients with an acute coronary syndrome with ST segment elevation and treated with angioplasty

Terminée

Remerciements de la Famille COLLET

Prix de Recherche Pr Jean-Philippe COLLET

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

logo étude

objectif

Impact of Abciximab versus placebo in patients with an acute coronary syndrome with ST segment elevation and treated with angioplasty

date de réalisation

1999

nombre de patients

300

nombre de centres participants

26 French centers

type de financement

Private (Lilly)

Publications

  • Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
    G Montalescot, P Barragan, O Wittenberg, P Ecollan, S Elhadad, P Villain, J M Boulenc, M C Morice, L Maillard, M Pansiéri, R Choussat, P Pinton, ADMIRAL Investigators
    Publicated in The New England Journal of Medecine
  • Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention
    J P Collet, G Montalescot, C Lesty, Z Mishal, J Soria, R Choussat, G Drobinski, C Soria, P Pinton, P Barragan, D Thomas
    Publicated in Circulation

Autres études

+

EDUC-DAI

En cours

Impact of therapeutic education on the quality of life and the anxiety of patients with a defibrillator.
Lire la suite
+

ANCHOR

En cours

Demonstrate the superiority of an association of VA-ECMO and IABP with an optimal medical treatment compared with an optimal medical treatment only in cardiogenic shock AMI patients
Lire la suite
+

ARCACHON

En cours

To demonstrate the non-inferiority of a strategy of simple clinical follow-up (without non-invasive stress testing) in asymptomatic CAD patients with a prior history of coronary revascularization comp...
Lire la suite